Ramakant Swayampakula

Analyst

HC Wainwright & Co.

Equibles does not estimate personal net worth.

About Ramakant Swayampakula

Ramakant Swayampakula is recorded as Analyst at HC Wainwright & Co.. Ramakant Swayampakula has spoken on 2 earnings calls across 2 companies, most recently for Evotec SE on July 14, 2026. Those appearances were for Evotec SE (EVO) and Innate Pharma SA (IPHA). The companies whose calls Ramakant Swayampakula spoke on are classified in the Healthcare sector.

Ramakant Swayampakula on recent calls

“What share of your profit, not revenue, has historically come from lumpy partner-controlled milestones? And at this point, are you re-resourcing, you know, towards recurring work so that you can manage that better?”

Analyst — HC Wainwright & Co., Earnings conference call (announced in 6-K) · July 14, 2026

“You know, regarding the Nectin 4 ADC, you know, you're – it's just Lily's products, which are in phase one, and bicycles, you know, recently deprioritized their product.”

Analyst — HC Wainwright & Co., Earnings conference call (announced in 6-K) · May 13, 2026